Molecular Biology Reports

, Volume 38, Issue 2, pp 1407–1411 | Cite as

Dopamine D2 receptor gene −141C Insertion/Deletion polymorphism in Turkish schizophrenic patients

  • Hulyam Kurt
  • Miris Dikmen
  • Ayşe Basaran
  • Cinar Yenilmez
  • Figen Ozdemir
  • Irfan Degirmenci
  • Hasan Veysi Gunes
  • Meral Urhan Kucuk
  • Fezan Mutlu
Article

Abstract

Schizophrenia is a chronic and neuropsychiatric disease that affects about 0.5–1% of the world’s population. An increase in dopamine and dopamine D2 receptor (DRD2) gene products has been well described in schizophrenic patients. Several groups have studied the relationship between dopaminergic hyperactivity and cellular communications have obtained discordant results. Studies searching for the relationship between the schizophrenia and DRD2 gene have gained more interest. Our objective was to determine the relationships among schizophrenic symptoms in schizophrenia subtypes and severity of symptoms in terms of DRD2 gene −141C Insertion/Deletion [Ins/Del; I/D] polymorphism by PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) assay method. Genomic DNA was prepared from peripheral blood by using salt extraction method. After amplification of genomic DNA, PCR products were digested with BstNI restriction enzyme for the detection of DRD2 gene −141C Ins/Del polymorphism in 73 schizophrenic patients and 60 healthy control subjects. The allelic frequencies of the DRD2 gene −141C Ins/Del polymorphism in case and control groups were 79.5 and 77.5% for I allele; 20.5 and 22.5% for D allele respectively. There was no significant difference in frequencies of genotypes and alleles between the two groups. In schizophrenic and control subjects, there were no significant relationship in severity of the disease and schizophrenia types among the −141C Ins/Del genotypes and alleles.

Keywords

DRD2 gene Polymorphism Schizophrenia −141C Ins/Del 

Notes

Acknowledgments

This study was supported by a grant of the Research Foundation of University of Eskisehir Osmangazi, Turkey (Grant No. 200011027).

References

  1. 1.
    Chen CH, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsia KJ (1997) Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 74(1):40–43CrossRefPubMedGoogle Scholar
  2. 2.
    Prasad S, Deshpande SN, Bhatia T, Wood J, Nimgaonhar VL, Thelma BK (1999) Association study of schizophrenia among Indian families. Am J Med Genet 88:298–300CrossRefPubMedGoogle Scholar
  3. 3.
    Missale C, Nash SR, Robinson SW, Jaber M, Caron MGD (1998) Opamine receptors: from structure to function. Physiol Rev 78(1):189–225PubMedGoogle Scholar
  4. 4.
    Jonsson EG, Nothen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M et al (1999) Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophr Res 9 40(1):31–36CrossRefGoogle Scholar
  5. 5.
    Virgos C, Martorell L, Valero J, Figuera L, Civeira F, Joven J et al (2001) Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr Res 49:65–71CrossRefPubMedGoogle Scholar
  6. 6.
    Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H et al (1994) Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343:703–704CrossRefPubMedGoogle Scholar
  7. 7.
    Mihara K, Kondo T, Suzuki A, Yasui N, Ona S, Otani K et al (2001) No relationship between −141C Ins/Del polymorphsim in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study. Psychiatry Res 101:33–38CrossRefPubMedGoogle Scholar
  8. 8.
    Rothschild LG, Badner J, Cravchik A, Gershan ES, Gejman PV (1996) No association detected between a D3 receptor gene-expressed variant and schizophrenia. Am J Med Genet 67(2):232–234CrossRefPubMedGoogle Scholar
  9. 9.
    Gelernter J, Kranzler H, Cubells FJ, Ichinose H, Nagatsu T (1998) DRD2 Allele frequencies and linkage disequilibria, including the −141 Ins/Del promoter polymorphism, in European-American, African-American, and Japanese subjects. Genomics 51:21–26CrossRefPubMedGoogle Scholar
  10. 10.
    Comings ED (1998) Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. Alcohol 16(1):61–70CrossRefPubMedGoogle Scholar
  11. 11.
    Schmauss C (1996) Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia. J Neurosci 16(24):7902–7909PubMedGoogle Scholar
  12. 12.
    Senogles ES (2000) The D2 dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Mol Pharmacol 58:455–462PubMedGoogle Scholar
  13. 13.
    Gelernter J, Kranzler H (1999) D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: no association with phenotype or severity of phenotype. Neuropsychopharmacology 20(4):640–649CrossRefPubMedGoogle Scholar
  14. 14.
    Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D et al (1994) No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia-analysis using denaturing gradient gel electrophoresis. JAMA 271(3):204–208CrossRefPubMedGoogle Scholar
  15. 15.
    Arinami T, Gao M, Hamaguchi H, Toru M (1997) A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6(4):577–582CrossRefPubMedGoogle Scholar
  16. 16.
    Breen G, Brown J, Maude S, Fox H, Collier D, Li T et al (1999) −141 C Del/Ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in British population. Am J Med Genet 88:407–410CrossRefPubMedGoogle Scholar
  17. 17.
    Stöber G, Jatzke S, Heils A, Jungkunz G, Knapp M, Mössner R et al (1998) Insertion/Deletion variant (−141 C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. J Neural Transm 105:101–109CrossRefPubMedGoogle Scholar
  18. 18.
    Mihara K, Suzuki A, Kondo T, Nagashima U, Ona S, Otani K et al (2000) No relationship between Taq 1 a polymorphism of dopamine D2 receptor gene and extrapyramidal adverse effects of selective dopamine D2 antagonists, bromperidol and namonapride in schizophrenia: a preliminary study. Am J Med Genet 96:422–424CrossRefPubMedGoogle Scholar
  19. 19.
    Ohara K, Nagai M, Tani K, Nakamura Y, Ino A, Ohara K (1998) Functional polymorphism of −141 Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res 81:117–123CrossRefPubMedGoogle Scholar
  20. 20.
    Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J (2001) Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia. Am J Med Genet 105(2):176–178CrossRefPubMedGoogle Scholar
  21. 21.
    American Psychiatry Association (APA) (1994) Diagnostic and statistical manual of mental disorders, 4th edn. DSM-IV, Washington DCGoogle Scholar
  22. 22.
    Kay SR, Fiszbein A, Opler LA et al (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMedGoogle Scholar
  23. 23.
    Güneş HV, Ata N, Değirmenci İ, Başaran A, Timuralp B, Dikmen M et al (2004) Frequency of angiotensin converting enzyme gene polymorphism in Turkish hypertensive patients. Int J Clin Pract 58(9):838–843CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Hulyam Kurt
    • 1
  • Miris Dikmen
    • 2
  • Ayşe Basaran
    • 1
  • Cinar Yenilmez
    • 3
  • Figen Ozdemir
    • 3
  • Irfan Degirmenci
    • 1
  • Hasan Veysi Gunes
    • 1
  • Meral Urhan Kucuk
    • 4
  • Fezan Mutlu
    • 5
  1. 1.Department of Medical Biology, Faculty of MedicalEskisehir Osmangazi UniversityEskisehirTurkey
  2. 2.Department of Pharmacology, Faculty of PharmacyAnadolu UniversityEskisehirTurkey
  3. 3.Department of Psychiatry, Faculty of MedicalEskisehir Osmangazi UniversityEskisehirTurkey
  4. 4.Department of Biology, Faculty of ScienceAdiyaman UniversityAdiyamanTurkey
  5. 5.Department of Biostatistics, Faculty of MedicalEskisehir Osmangazi UniversityEskisehirTurkey

Personalised recommendations